MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 44 filers reported holding MERUS N V in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $27,388,000 | +19.2% | 1,311,039 | 0.0% | 1.65% | +20.3% |
| Q4 2020 | $22,983,000 | +46.1% | 1,311,039 | 0.0% | 1.37% | +17.2% |
| Q3 2020 | $15,732,000 | -25.4% | 1,311,039 | 0.0% | 1.17% | -12.3% |
| Q2 2020 | $21,095,000 | -11.1% | 1,311,039 | -33.1% | 1.33% | -39.4% |
| Q1 2020 | $23,729,000 | -14.1% | 1,961,039 | 0.0% | 2.20% | +10.3% |
| Q4 2019 | $27,611,000 | -21.0% | 1,961,039 | 0.0% | 1.99% | -37.0% |
| Q3 2019 | $34,946,000 | +21.6% | 1,961,039 | 0.0% | 3.16% | +19.7% |
| Q2 2019 | $28,729,000 | -0.8% | 1,961,039 | 0.0% | 2.64% | -5.4% |
| Q1 2019 | $28,965,000 | +5.5% | 1,961,039 | 0.0% | 2.79% | -18.4% |
| Q4 2018 | $27,455,000 | -29.1% | 1,961,039 | 0.0% | 3.42% | -0.9% |
| Q3 2018 | $38,711,000 | -56.6% | 1,961,039 | -50.0% | 3.45% | -39.4% |
| Q2 2018 | $89,266,000 | +145.7% | 3,922,078 | +100.0% | 5.69% | -8.8% |
| Q1 2018 | $36,338,000 | – | 1,961,039 | – | 6.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |